[1]
S. R. Salih, A. H. Majeed, K. M. Hussein, Y. S. Yasin, and A. H. Jumaa, “Dual Drug Repurposing in Cervical Cancer: The Synergistic Cytotoxic Effect of Dapagliflozin-Etoricoxib and Its Predicted Modulation of PI3K/Akt/mTOR Signaling via Molecular Docking”, Asian Pac J Cancer Biol, vol. 10, no. 4, pp. 821–835, Oct. 2025.